CHOP scientist receives 2013 E. Donnall Thomas Prize for analysis in bleeding disorder hemophilia Katherine A www.clomid25.com . Large, M.D., of The Kids's Hospital of Philadelphia was honored for her trailblazing scientific and clinical study in the bleeding disorder hemophilia when she received the 2013 E. Donnall Thomas Prize from the American Culture of Hematology at its annual meeting on Dec. 9 in New Orleans. Named for the late Nobel Prize laureate E. Donnall Thomas, the award recognizes pioneering study achievements in hematology that have helped move the field forwards. An internationally recognized expert in the molecular basis of hemophilia, Dr. High has developed novel methods to correcting hemophilia with gene therapy in research over the past two decades.
PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will survey findings that suggest comprehensive maternal hemorrhage protocols decrease utilization of blood products and improve individual safety. A scholarly research performed at Dignity Health, the fifth largest healthcare system in the United States with 31 obstetrical products, showed that the implementation of a standardized comprehensive maternal hemorrhage process directed towards prevention and treatment of maternal hemorrhage significantly reduced blood product utilization and led to a 45 percent reduction in puerperal hysterectomy.